Danaher Corporation (FRA:DAP)

Market Cap	127.83B
Revenue (ttm)	20.50B
Net Income (ttm)	2.91B
Shares Out	n/a
EPS (ttm)	4.02
PE Ratio	43.88
Forward PE	25.44
Dividend	1.07 (0.61%)
Ex-Dividend Date	Jun 27, 2025

Volume	33
Average Volume	967
Open	179.58
Previous Close	177.74
Day's Range	179.34 - 179.58
52-Week Range	149.72 - 258.00
Beta	n/a
RSI	59.15
Earnings Date	Jul 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DAP

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD